Security key
44930G107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 26,049,203
- Total 13F value
- $3,820,042,951
- Share change
- +936,619
- Put/Call ratio
- 22%
- SEC-reported price per share
- $146.60
- Number of holders
- 286
- Value change
- +$140,451,077
- Number of buys
- 161
- Number of sells
- 113
- Shares outstanding
- 25,012,080
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
286
Top holders
10
ICUI full security history
Ownership snapshot
Full 13F holder table
ICU MEDICAL INC/DE SEC filings
ICU MEDICAL INC/DE company facts
Broader feeds
Ownership snapshot
Top reported holders of ICUI - ICU MEDICAL INC/DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: Janus Henderson Group Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Janus Henderson Group Ltd. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership
Top 5
Janus Henderson Group Ltd.
11%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.8%
FULLER & THALER ASSET MANAGEMENT,...
5.2%
VANGUARD CAPITAL MANAGEMENT LLC
5.2%
Vivek Jain
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Janus Henderson Group Ltd. |
13D/G
13F
Company
|
11%
|
$422,500,414
2,781,621 shares
|
+$47,309,938 | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
Vanguard Portfolio Management · Company
|
5.8%
|
$188,012,050
1,455,765 shares
|
$0 | 31 Mar 2026 |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13D/G
13F
Company
|
5.2%
|
$197,172,504
1,298,127 shares
|
+$11,784,841 | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.2%
|
$167,695,980
1,298,459 shares
|
$0 | 31 Mar 2026 |
| Vivek Jain |
3/4/5
Chairman and CEO, Director
|
1.1%
|
$42,774,733
279,172 shares
|
— | 15 Mar 2026 |
| David C. Greenberg |
3/4/5
Director
|
0.04%
|
$1,426,865
9,714 shares
mixed-class rows
|
-$297,934 | 13 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
286
Shares
26,049,203
Rows available
286
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
276
Q2 2026 holders
286
Holder diff
10
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|